Targeting mTOR Signaling in Cancer: The Promise of Natural Product-derived Inhibitors
Anticancer Research · 2026
DOI: 10.21873/anticanres.17969 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Anticancer Research, 2026. Verfasst von Pithi Chanvorachote und 3 weiteren Autor:innen. Beteiligte Einrichtung: Center of Excellence in Cancer Cell and Molecular Biology, Faculty of Pharmaceutical Sciences, Chulalongkorn University, Bangkok, Thailand. Hauptthemen laut MEDLINE: Signal Transduction, TOR Serine-Threonine Kinases, Biological Products, MTOR Inhibitors.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Center of Excellence in Cancer Cell and Molecular Biology, Faculty of Pharmaceutical Sciences, Chulalongkorn University, Bangkok, Thailand.
- Department of Pharmacology and Physiology, Faculty of Pharmaceutical Sciences, Chulalongkorn University, Bangkok, Thailand.
- Department of Biochemistry and Microbiology, Faculty of Pharmaceutical Sciences, Chulalongkorn University, Bangkok, Thailand.
- Center of Excellence in Cancer Cell and Molecular Biology, Faculty of Pharmaceutical Sciences, Chulalongkorn University, Bangkok, Thailand preedakorn.c@chula.ac.th preedakorn.chun@gmail.com.
Zitieren
APA
Chanvorachote, P., Chaotham, C., Ei, Z. Z., & Chunhacha, P. (2026). Targeting mTOR Signaling in Cancer: The Promise of Natural Product-derived Inhibitors. Anticancer Research. https://doi.org/10.21873/anticanres.17969
Vancouver
Chanvorachote P, Chaotham C, Ei ZZ, Chunhacha P. Targeting mTOR Signaling in Cancer: The Promise of Natural Product-derived Inhibitors. Anticancer Research. 2026. doi:10.21873/anticanres.17969
BibTeX
@article{Chanvorachote2026,
author = {Chanvorachote, Pithi and Chaotham, Chatchai and Ei, Zin Zin and Chunhacha, Preedakorn},
title = {Targeting mTOR Signaling in Cancer: The Promise of Natural Product-derived Inhibitors},
journal = {Anticancer Research},
year = {2026},
doi = {10.21873/anticanres.17969}
}
EUVIMED